…
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Hinge Health operates a digital musculoskeletal care platform offering virtual physical therapy, wearable sensors, coaching and care-management software to employers, health plans and providers. Long-term growth may be driven by a large addressable MSK burden, employers' focus on cost reduction, expansion into payer and Medicare channels and product extensions that support recurring enterprise revenue, which appears positioned to appeal to investors seeking data-driven, outcomes-focused healthcare solutions.
Principal risks include ongoing unprofitability and cash burn, significant competition and execution risk in scaling payer adoption and reimbursement, customer concentration with employer contracts and data privacy/security exposure.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Income before tax | -527.26M | -11.26M | -108.55M |
| Net income | -528.26M | -11.93M | -108.14M |
| Selling general administrative | 325.48M | 62.39M | 67.02M |
| Selling and marketing expenses | 313.93M | 165.14M | 147.62M |
| Gross profit | 469.30M | 300.59M | 194.18M |
| Reconciled depreciation | 5.13M | 5.95M | 5.63M |
| Ebit | -541.02M | -24.43M | -130.51M |
| Ebitda | -535.89M | -22.08M | -128.39M |
| Depreciation and amortization | 5.13M | 2.35M | 2.13M |
| Operating income | -546.37M | -31.91M | -130.51M |
| Other operating expenses | 1134.23M | 422.31M | 423.24M |
| Tax provision | 1.00M | 0.68M | -0.41M |
| Income tax expense | 1.00M | 0.68M | -0.41M |
| Total revenue | 587.86M | 390.40M | 292.73M |
| Total operating expenses | 1015.67M | 332.50M | 324.69M |
| Cost of revenue | 118.56M | 89.81M | 98.55M |
| Total other income expense net | 19.11M | 20.65M | 21.97M |
| Net income from continuing ops | -528.26M | -11.93M | -108.14M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Total assets | 744.76M | 673.26M | 622.53M |
| Intangible assets | 2.51M | 1.81M | 2.19M |
| Other current assets | 88.34M | 63.51M | 46.67M |
| Total liab | 366.23M | 256.56M | 195.25M |
| Total stockholder equity | 378.54M | 416.70M | 427.28M |
| Other current liab | 57.33M | 25.73M | 30.85M |
| Capital stock | 199.87M | 851.27M | 851.27M |
| Retained earnings | -1051.00M | -522.74M | -510.80M |
| Good will | 64.10M | 61.61M | 61.61M |
| Cash | 208.00M | 300.79M | 234.95M |
| Total current liabilities | 362.41M | 249.30M | 184.16M |
| Current deferred revenue | 300.86M | 217.63M | 140.47M |
| Net debt | -199.96M | -289.71M | -219.22M |
| Short term debt | 4.22M | 3.81M | 4.64M |
| Short long term debt total | 8.04M | 11.07M | 15.73M |
| Other stockholder equity | 1229.68M | 88.10M | 86.75M |
| Total current assets | 533.90M | 583.45M | 529.88M |
| Long term investments | 113.17M | 0.00M | - |
| Short term investments | 155.87M | 165.79M | 188.40M |
| Net receivables | 66.06M | 42.49M | 46.56M |
| Inventory | 15.64M | 10.87M | 13.29M |
| Accounts payable | 57.33M | - | - |
| Accumulated other comprehensive income | -0.02M | 0.07M | 0.06M |
| Non currrent assets other | 13.73M | 9.41M | 6.38M |
| Non current assets total | 210.86M | 89.81M | 92.65M |
| Capital lease obligations | 8.04M | 11.07M | 15.73M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Investments | -103.70M | 18.31M | 1.50M |
| Total cashflows from investing activities | -113.76M | 18.31M | 1.50M |
| Net borrowings | 4.93M | 0.00M | 0.00M |
| Total cash from financing activities | -150.47M | -2.20M | -3.00M |
| Net income | -528.26M | -11.93M | -108.14M |
| Change in cash | -92.79M | 65.11M | -65.41M |
| Begin period cash flow | 302.59M | 237.47M | 302.88M |
| End period cash flow | 209.80M | 302.59M | 237.47M |
| Total cash from operating activities | 171.44M | 49.00M | -63.91M |
| Issuance of capital stock | 255.68M | 0.00M | 0.00M |
| Depreciation | 5.49M | 5.95M | 5.63M |
| Other cashflows from investing activities | -5.36M | -2.73M | -2.64M |
| Change to inventory | -4.76M | 0.61M | 10.56M |
| Change to account receivables | -26.63M | -1.34M | -23.13M |
| Sale purchase of stock | -65.03M | 0.00M | 0.00M |
| Other cashflows from financing activities | -350.64M | -2.81M | -3.00M |
| Capital expenditures | 0.71M | 3.77M | 4.62M |
| Change in working capital | -2.01M | 13.50M | 9.41M |
| Stock based compensation | 643.01M | 0.74M | 1.65M |
| Other non cash items | 53.16M | 41.33M | 28.02M |
| Free cash flow | 170.73M | 45.23M | -68.52M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HNGE Hinge Health, Inc. |
3.59 3.90% |
95.57 | 11.53 | 32.79 | 10.35 | 22.21 | 10.09 | 73.84 |
| VEEV Veeva Systems Inc Class A |
5.84 2.12% |
280.68 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
114.56 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
2.77 3.37% |
85.01 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
0.21 3.90% |
5.59 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
455 Market Street, San Francisco, CA, United States, 94105
415 726 2206
1437
| Name | Title | Year Born |
|---|---|---|
| Mr. Gabriel Mecklenburg | Co-Founder, CTO & Executive Chairman | 1989 |
| Mr. Daniel A. Perez | Co-Founder, CEO & Director | 1986 |
| Mr. James Pursley | President | 1980 |
| Mr. James W. Budge | Chief Financial Officer | 1967 |
| Mr. Alexander Annison | Chief Operating Officer | NA |
| Bianca Buck | Finance & Head of Investor Relations | NA |
| Mr. David Wood | General Counsel | NA |
| Ms. Erin Wilson | Senior Vice President of Sales & Strategy | NA |
| Dr. Jeffrey Krauss M.D. | Chief Medical Officer | NA |
| Mr. Hassan Asghar | Chief Information Security Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.